Outcomes | Preterm (<30 weeks) N = 200 | Preterm (30–36 weeks) N = 1066 | Term (≥37 weeks) N = 462a |
---|---|---|---|
Genderb | |||
Male | 106 (53%) | 560 (53%) | 240 (52%) |
Female | 94 (47%) | 506 (47%) | 222 (48%) |
Death or serious neonatal morbidity: composite primary outcome (one or more of death, severe RDSc, BPDd, IVHe [grade III/IV], cystic PVLf, NECg) | 126 (64%) | 107 (10%) | 2 (<0.01%) |
Missing | 0 (0%) | 0 (0%) | 1 (<0.01%) |
Death or neurologic impairment at 18–24 months: composite primary outcome (one or more of death, cerebral palsy or cognitive delay) | 89 (45%) | 128 (12.0%) | 27 (6%) |
Missing | 1 (0.01%) | 5 (0.1%) | 2 (<0.01%) |
Death or severe disability (neuromotor, neurosensory, neurocognitive) at 5 years § | 104 (52%) | 237 (22%) | 86 (19%) |